Zijin Mng Gr Co ADR (ZIJMY) 8.0500 $ZIJMY Update: Zijin

Diving into Landis+Gyr's Major Utility Win When news hits about a deal secured by Landis+Gyr Group AG, it rings a few bells across the utility landscape. These folks have brewed up a storm with a fresh contract that slots into their rapidly expanding portfolio of grid-savvy products. So, what’s the fuss about this latest agreement? A Groundbreaking Contract Now, this...

Rolling Out Dough and Kindness in West Virginia In a world that's more uncertain than a penny stock, here comes a story that'll warm even the coldest heart: Little Caesars is sending their Love Kitchen into West Virginia, aiming to serve piping hot pizza to about 8,000 folks in need. Fueled by the efforts of local franchisee Vicki Dunn-Marshall and her team, they're...

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

A Different Approach to Mindfulness No two readers will walk away from Ihrie Means' We Come Here For The Flowers with the same experience—that's the beauty of this visual feast. The author's way of blending art with deep, spiritual musings is like a refreshing cup of morning joe, hits you when you least expect it. The book doesn’t throw text-heavy sermons at you;...

A New Dawn for Endometrial Cancer Treatment Alright, every once in a while, something shakes up the world of oncology. And that's exactly what's happening with sacituzumab tirumotecan, or sac-TMT if you want to save your breath. This new drug is stepping up as a future star in the fight against endometrial cancer, according to an eye-popping international study led by NYU...

It'Sugar Faces Class Action Over Employee Rights Looks like the sugar rush turned into a legal headache for It'Sugar, a renowned candy retailer, as they're now tangled up in a class action lawsuit. This one's not just about spilled sprinkles—it's about alleged deep-rooted violations of California's labor laws. The Zakay Law Group, a labor law outfit outta San Diego, has...

Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Strategic Moves by Ashcroft Capital for 2025 Ashcroft Capital, a multi-faceted real estate investment firm, is gearing up for an exciting year ahead as it focuses on strategic acquisitions in the multifamily sector. Their latest achievement is the recapitalization of The Avery, a luxurious apartment community renowned for its excellent living standards. The...

BCE Inc. Announces Renewal of Normal Course Issuer Bid BCE Inc. is proud to share that it has secured approval from the Toronto Stock Exchange (the "TSX") for the renewal of its normal course issuer bid ("NCIB"). This program enables BCE to repurchase up to 10% of the public float of its outstanding First Preferred Shares, which are traded on the TSX. Details of the NCIB...

Monopar's Presentation at the American Neurological Association Meeting Monopar Therapeutics Inc. is excited to share groundbreaking new data regarding the long-term neurological efficacy and safety of its investigational therapy, ALXN1840, targeting Wilson disease, at the upcoming 150th American Neurological Association (ANA) Annual Meeting. Renowned neurologist Dr....

Legal Action Against DexCom, Inc. Pomerantz LLP has recently announced a significant class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) and some of its officers. This legal action, which has been filed in a U.S. District Court, aims to represent those individuals and entities who purchased DexCom securities within a specified timeline. The lawsuit seeks to recover...

Red Roof Partners with Canine Companions to Make a Difference Red Roof®, a well-respected name in the lodging industry, is renewing its partnership with Canine Companions to bring a unique initiative called the Room In Your Heart® program to fruition. This program aims not only to offer discounts to travelers but also to support the vital cause of providing trained...